Mylan (MYL) and Theravance Biopharma (TBHP) Report FDA Acceptance of New Drug Application for Revefenacin (TD-4208)
Tweet Send to a Friend
Theravance Biopharma, Inc. (NASDAQ: TBPH) and Mylan N.V. (NASDAQ: MYL) today announced that the U.S. Food and Drug Administration (FDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
